Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Uncertainty and innovation: Understanding the role of cell-based manufacturing facilities in shaping regulatory and commercialization environments.

Isasi R, Rahimzadeh V, Charlebois K.

Appl Transl Genom. 2016 Nov 11;11:27-39. doi: 10.1016/j.atg.2016.11.001.

2.

Community genetics: Genetics boosts US-Cuban links.

Isasi R, Zuchner SL, Villafranca RC.

Nature. 2016 Nov 17;539(7629):357. doi: 10.1038/539357d. No abstract available.

PMID:
27853218
3.

GENETIC TECHNOLOGY REGULATION. Editing policy to fit the genome?

Isasi R, Kleiderman E, Knoppers BM.

Science. 2016 Jan 22;351(6271):337-9. doi: 10.1126/science.aad6778. No abstract available.

PMID:
26797999
4.

Data sharing in stem cell translational science: policy statement by the International Stem Cell Forum Ethics Working Party.

Bredenoord AL, Mostert M, Isasi R, Knoppers BM.

Regen Med. 2015;10(7):857-61. doi: 10.2217/rme.15.42.

PMID:
26506014
5.

Developing Educational Resources to Advance Umbilical Cord Blood Banking and Research: A Canadian Perspective.

Pereira Beak C, Chargé SB, Isasi R, Knoppers BM.

J Obstet Gynaecol Can. 2015 May;37(5):443-50.

PMID:
26168106
6.

CRISPR germline engineering--the community speaks.

Bosley KS, Botchan M, Bredenoord AL, Carroll D, Charo RA, Charpentier E, Cohen R, Corn J, Doudna J, Feng G, Greely HT, Isasi R, Ji W, Kim JS, Knoppers B, Lanphier E, Li J, Lovell-Badge R, Martin GS, Moreno J, Naldini L, Pera M, Perry AC, Venter JC, Zhang F, Zhou Q.

Nat Biotechnol. 2015 May;33(5):478-86. doi: 10.1038/nbt.3227. No abstract available.

PMID:
25965754
7.

Oversight of human inheritable genome modification.

Isasi R, Knoppers BM.

Nat Biotechnol. 2015 May;33(5):454-5. doi: 10.1038/nbt.3231. No abstract available.

PMID:
25965749
8.

Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI).

Andrews PW, Baker D, Benvinisty N, Miranda B, Bruce K, Brüstle O, Choi M, Choi YM, Crook JM, de Sousa PA, Dvorak P, Freund C, Firpo M, Furue MK, Gokhale P, Ha HY, Han E, Haupt S, Healy L, Hei DJ, Hovatta O, Hunt C, Hwang SM, Inamdar MS, Isasi RM, Jaconi M, Jekerle V, Kamthorn P, Kibbey MC, Knezevic I, Knowles BB, Koo SK, Laabi Y, Leopoldo L, Liu P, Lomax GP, Loring JF, Ludwig TE, Montgomery K, Mummery C, Nagy A, Nakamura Y, Nakatsuji N, Oh S, Oh SK, Otonkoski T, Pera M, Peschanski M, Pranke P, Rajala KM, Rao M, Ruttachuk R, Reubinoff B, Ricco L, Rooke H, Sipp D, Stacey GN, Suemori H, Takahashi TA, Takada K, Talib S, Tannenbaum S, Yuan BZ, Zeng F, Zhou Q.

Regen Med. 2015;10(2 Suppl):1-44. doi: 10.2217/rme.14.93. No abstract available.

PMID:
25675265
9.

The DISCUSS Project: Revised Points to Consider for the Derivation of Induced Pluripotent Stem Cell Lines From Previously Collected Research Specimens.

Lomax GP, Hull SC, Isasi R.

Stem Cells Transl Med. 2015 Feb;4(2):123-9. doi: 10.5966/sctm.2014-0192. Review.

10.

Research ethics and stem cells: Is it time to re-think current approaches to oversight?

Caulfield T, Kamenova K, Ogbogu U, Zarzeczny A, Baltz J, Benjaminy S, Cassar PA, Clark M, Isasi R, Knoppers B, Knowles L, Korbutt G, Lavery JV, Lomax GP, Master Z, McDonald M, Preto N, Toews M.

EMBO Rep. 2015 Jan;16(1):2-6. doi: 10.15252/embr.201439819. No abstract available.

11.

CellCAN: a unique enabler of regenerative medicine and cell therapy in Canada.

Roy DC, Alarco AM, Isasi R.

Stem Cells Dev. 2014 Dec;23 Suppl 1:24-8. doi: 10.1089/scd.2014.0354.

PMID:
25457957
12.

Identifiability and privacy in pluripotent stem cell research.

Isasi R, Andrews PW, Baltz JM, Bredenoord AL, Burton P, Chiu IM, Hull SC, Jung JW, Kurtz A, Lomax G, Ludwig T, McDonald M, Morris C, Ng HH, Rooke H, Sharma A, Stacey GN, Williams C, Zeng F, Knoppers BM.

Cell Stem Cell. 2014 Apr 3;14(4):427-30. doi: 10.1016/j.stem.2014.03.014.

13.

Stem cell research funding policies and dynamic innovation: a survey of open access and commercialization requirements.

Lévesque M, Kim JR, Isasi R, Knoppers BM, Plomer A, Joly Y.

Stem Cell Rev. 2014 Aug;10(4):455-71. doi: 10.1007/s12015-014-9504-5.

14.

A review of the key issues associated with the commercialization of biobanks.

Caulfield T, Burningham S, Joly Y, Master Z, Shabani M, Borry P, Becker A, Burgess M, Calder K, Critchley C, Edwards K, Fullerton SM, Gottweis H, Hyde-Lay R, Illes J, Isasi R, Kato K, Kaye J, Knoppers B, Lynch J, McGuire A, Meslin E, Nicol D, O'Doherty K, Ogbogu U, Otlowski M, Pullman D, Ries N, Scott C, Sears M, Wallace H, Zawati MH.

J Law Biosci. 2014 Feb 25;1(1):94-110. No abstract available.

15.

Policy recommendations for addressing privacy challenges associated with cell-based research and interventions.

Ogbogu U, Burningham S, Ollenberger A, Calder K, Du L, El Emam K, Hyde-Lay R, Isasi R, Joly Y, Kerr I, Malin B, McDonald M, Penney S, Piat G, Roy DC, Sugarman J, Vercauteren S, Verhenneman G, West L, Caulfield T.

BMC Med Ethics. 2014 Feb 3;15:7. doi: 10.1186/1472-6939-15-7.

16.

Fostering public cord blood banking and research in Canada.

Isasi R, Dalpe G, Knoppers BM.

Stem Cells Dev. 2013 Dec;22 Suppl 1:29-34. doi: 10.1089/scd.2013.0381.

PMID:
24304072
17.

The DISCUSS Project: induced pluripotent stem cell lines from previously collected research biospecimens and informed consent: points to consider.

Lomax GP, Hull SC, Lowenthal J, Rao M, Isasi R.

Stem Cells Transl Med. 2013 Oct;2(10):727-30. doi: 10.5966/sctm.2013-0099.

18.
19.

Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation.

Bubela T, Reshef A, Li MD, Atkins H, Caulfield T, Culme-Seymour E, Gold ER, Illes J, Isasi R, McCabe C, Ogbogu U, Piret J, Mason C.

Regen Med. 2012 Nov;7(6):735-40. doi: 10.2217/rme.12.59. No abstract available.

20.

Disclosure and management of research findings in stem cell research and banking: policy statement.

Isasi R, Knoppers BM, Andrews PW, Bredenoord A, Colman A, Hin LE, Hull S, Kim OJ, Lomax G, Morris C, Sipp D, Stacey G, Wahlstrom J, Zeng F; International Stem Cell Forum Ethics Working Party..

Regen Med. 2012 May;7(3):439-48. doi: 10.2217/rme.12.23.

PMID:
22594334

Supplemental Content

Support Center